FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
FDA proposes pulling ineffective cold medicine from shelves
When you're feeling under the weather, you likely grab your go-to cough and cold medicine. But are all the ingredients helping you fight off that cold?
FDA wants to ban decongestant found in cold, allergy medicine
Dodgers' Shohei Ohtani Bid Pays Off: 2x MVP Rumored to Have Generated a Humongous 100M+ Revenue In His Debut Year Meet Ameca, the world's 'most advanced' humanoid robot What 50 legendary musicians looked like at the start of their careers 15 Foods That Barbara Bush Loved Stocks soared on news of Trump's election.
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA's advisory panel ruled it should no longer be considered an effective drug.
FDA moves to pull popular cold and flu medicines from shelves
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve nasal congestion.
FDA proposes ending use of popular decongestant in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective,
FDA considers pulling some cold medicine
FDA considers pulling some cold medicine
WSB-TV1d
FDA proposes pulling oral phenylephrine, found in many decongestants, from shelves
The Food and Drug Administration proposed that oral phenylephrine be removed from store shelves becasue the treatment ...
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex.The U.S. Food and Drug Administration (FDA) ...
Medpage Today on MSN1d
FDA Adds New Warning to GLP-1 Drugs
The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...
What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...
USA TODAY on MSN2d
Does your dog have arthritis? A lot of them do. But treatment can be tricky
Dogs get arthritis for different reasons than humans, and the pain threatens the nature of our relationship with our pets.
Business Wire12d
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
Many individuals prefer oral medications over injectables, and the simplicity of taking a daily pill can make it easier ...
Viking rises after 'competitive' efficacy, safety data from oral weight-loss drug
(Reuters) -Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce ...
BioPharma Dive5d
Viking data provide latest test of oral obesity drug potential
Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...
Medical News Today3d
Losartan oral tablet dosage
Losartan is a generic oral tablet used to treat high blood pressure and related conditions. Find out what the recommended dosages are, how to take the drug, and more.
Viking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High Expectations
Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...
health.economictimes.indiatimes1d
Weight Loss drugs may alter treatment paradigm for chronic disorders, say experts
Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...